Laborde_Thomas.jpg

Thomas LaBorde

Dr. Thomas LaBorde has been named medical director of ClearSky Rehabilitation Hospital of Leesville. In this role, he will lead the hospital’s interdisciplinary team in providing specialized rehabilitative services to patients living with disabling injuries or illnesses, including strokes, brain injuries, hip fractures, spinal injuries, Parkinson’s disease, multiple sclerosis, COVID-19, and other debilitating conditions.

Board certified in physical medicine and rehabilitation, LaBorde earned a bachelor’s degree from the University of Southwestern Louisiana in Lafayette, La. He earned a medical degree from Louisiana State University School of Medicine in New Orleans, and completed a residency in physical medicine and rehabilitation at Baylor College of Medicine affiliated hospitals in Houston.

LaBorde is specially trained in neuromusculoskeletal disorders, pain management, pain medicine, electrodiagnostic medicine, and electromyography. He has served on hospital staffs of numerous medical facilities throughout Louisiana since 1977, and has held academic appointments at Baylor College of Medicine, Louisiana State University, and University of Southwestern Louisiana.

LaBorde is a fellow of both the American College of Pain Medicine and the American Academy of Physical Medicine and Rehabilitation. He also is a member of the Louisiana State Medical Society and Louisiana Physical Medicine and Rehabilitation Society, and participates in other professional and community organizations.

Locations

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.